Viewing nowCombinationAmolrtan Tablet 5/160mg
Valsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.

MFDS item code 201308478 · Approved 2013.07.30 · Insurance code 648602530
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension who have difficulty controlling blood pressure with monotherapy of amlodipine or valsartan. It helps effectively manage hypertension, stabilize blood pressure, and prevent cardiovascular complications.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction/cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.
The use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.
This medication may cause serious harm to the fetus and newborn if taken during the second and third trimester of pregnancy, so it should be stopped immediately upon confirmation of pregnancy. It should not be used by individuals allergic to the active ingredients or similar class of medicines, by pregnant or lactating women, or by patients with severe renal or liver dysfunction. Patients with body sodium or hydration deficit may experience low blood pressure, so their condition should be checked thoroughly before taking the medication, and they should be monitored carefully at the start of treatment. Patients with high potassium levels or those taking potassium-sparing medications should have their potassium concentration checked frequently, and caution is needed for patients with impaired renal function. For patients with renal vascular problems or those who have recently received a kidney transplant, renal function should be closely monitored when administering this medication. This medication can cause serious side effects such as angioedema. If swelling of the face or neck or difficulty breathing occurs, medication should be stopped immediately. Patients with heart failure or post-myocardial infarction should closely monitor renal function and blood pressure changes while taking this medication, as pulmonary edema may occur in some heart failure patients. The risk of hypotension, renal dysfunction, and hyperkalemia may increase when this medication is taken with other antihypertensive drugs, so it should be taken as directed by the attending physician. Caution is advised as dizziness or fatigue may occur while driving or operating machinery. In case of overdose, severe hypotension or tachycardia may occur, and immediate medical treatment is required. The safety and efficacy of this medication in pediatric patients under 18 years of age have not been sufficiently established, therefore its use is not recommended. For the elderly, similar doses to those for adults are used, but caution is advised considering their physical condition. Women who are pregnant or planning to become pregnant or those who are breastfeeding are advised not to use this medication, and if planning pregnancy, consultation with a doctor is necessary.
Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, itching, joint swelling, back pain, arthritis, muscle spasms, lethargy, frequent urination, polyuria, erectile dysfunction, edema, pedal edema, facial swelling, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, renal impairment, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, intestinal vascular swelling, double vision, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste disturbance, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, dysuria, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest pain, weight gain, arthralgia, musculoskeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neuroexcitability, sensory loss, Stevens-Johnson syndrome
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius to preserve its effectiveness.
Dark yellow rectangular film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.